Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Antiviral prophylaxis

Guidance setting out the circumstances in which it may be appropriate to offer prophylactic antivirals to patients with a serious underlying medical condition or who are pregnant during the H1N1 swine influenza pandemic has been published by the Department of Health.

The document points out that routine prophylaxis is not recommended for most contacts of a case of H1N1 infection but that clinical judgement can be used for individuals who are at particularly high risk of flu complications.

Citation: The Pharmaceutical Journal URI: 10983015

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.